Story at-a-glance
- The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure
- John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
- Beaudoin received all the death certificates in Massachusetts from 2015 to 2022, finding 1,840 excess deaths from acute renal failure from January 1, 2021, to November 30, 2022, which he believes may be due to remdesivir
- A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients
- The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used
https://media.mercola.com/ImageServer/Public/2023/March/PDF/criminal-investigation-excess-deaths-remdesivir-pdf.pdf
More Lawsuits Filed Against Remdesivir
Two women are suing Kaiser Permanente and Redlands Community Hospital inCalifornia for giving remdesivir to their husbands without consent. Both men died fromkidney and organ failure after being administered remdesivir. “The day he was admittedon August 12 they started the remdesivir and on [August 17] is when they were done,”Christina Briones told CBS News. “Five doses. [On] the 17th his kidneys started to fail.”
In California, lawsuits have been fi led on behalf of at least 14 families against medicalproviders for prescribing remdesivir without providing necessary information about it,leading to the patients’ deaths.
Another wrongful death suit was fi led in Nevada, after apatient died of kidney failure and respiratory failure a week after being given remdesivir.
